AbbVie | ABBV - Ebit




AbbVie reported $5.33B in EBIT for its fiscal quarter ending in December of 2024.

Ebit Change Date
AbbVie USD 5.33B 2.53B Dec/2024
Abbott USD 2.66B 805M Dec/2024
ALKERMES USD 162.69M 46.46M Dec/2024
Amgen USD 4.03B 11M Dec/2024
AstraZeneca USD 4.2B 119M Dec/2024
Biogen USD 644.1M 100.9M Dec/2024
BioMarin Pharmaceutical USD 161.41M 47.51M Dec/2024
Bristol-Myers Squibb USD 4.21B 2.03B Dec/2024
Eisai JPY 18.98B 12.87B Mar/2024
Eli Lilly USD 5.63B 3.88B Dec/2024
Gilead Sciences USD 3.11B 144M Dec/2024
GlaxoSmithKline GBP 1.43B 1.33B Dec/2024
J&J USD 5.35B 1.81B Dec/2024
Medtronic USD 2.17B 128M Jan/2025
Merck USD 5.22B 805M Dec/2024
Neurocrine Biosciences USD 142M 41.8M Dec/2024
Novartis USD 4.86B 286M Dec/2024
Pacira USD 48.91M 9.2M Sep/2024
Perrigo USD 182.4M 212.3M Sep/2024
Pfizer USD 4.62B 2.42B Dec/2024
Regeneron Pharmaceuticals USD 1.57B 67.9M Dec/2024
Roche Holding CHF 11.29B 2.68B Jun/2024
Sanofi EUR 2.08B 1.69B Dec/2024
UCB EUR 334M 163M Jun/2024
Ultragenyx Pharmaceutical USD -122278000 9.71M Dec/2024
United Therapeutics USD 343.1M 23.8M Sep/2024
Vertex Pharmaceuticals USD 1.2B 108.8M Dec/2024
Zoetis USD 988M 30M Dec/2024